Quarterly report pursuant to Section 13 or 15(d)

Segment Information (Tables)

v3.19.3
Segment Information (Tables)
9 Months Ended
Sep. 30, 2019
Segment Reporting [Abstract]  
Schedule of segment reporting information
    Three months Ended
September 30,
    Nine Months Ended
September 30,
 
    2019     2018     2019     2018  
Revenues                        
Real property operating   $ 264,141     $ 272,444     $ 795,656     $ 847,939  
Medical related consulting services – related parties     108,520       71,398       234,214       213,394  
Development services and sales of developed    products     10,555       69,661       37,237       156,176  
      383,216       413,503       1,067,107       1,217,509  
Depreciation and amortization                                
Real property operating     41,121       32,624       122,682       97,873  
Medical related consulting services     550       4,706       4,037       12,703  
Development services and sales of developed products     103,248       98,298       303,320       273,027  
      144,919       135,628       430,039       383,603  
Interest expense                                
Real property operating     -       25,205       32,877       287,123  
Other (a)     11,198       -       27,423       -  
      11,198       25,205       60,300       287,123  
Net loss                                
Real property operating     (3,190 )     542       (105,569 )     (231,541 )
Medical related consulting services     (200,832 )     (75,484 )     (445,529 )     (232,502 )
Development services and sales of developed products     (1,163,250 )     (146,451 )     (1,641,438 )     (443,479 )
Other (a)     (2,966,786 )     (2,181,858 )     (11,085,274 )     (4,390,513 )
    $ (4,334,058 )   $ (2,403,251 )   $ (13,277,810 )   $ (5,298,035 )

 

Identifiable long-lived tangible assets at September 30, 2019 and December 31, 2018   September 30,
2019
    December 31,
2018
 
Real property operating   $ 7,791,863     $ 7,898,224  
Medical related consulting services     270,177       6,852  
Development services and sales of developed products     338,533       224,364  
    $ 8,400,573     $ 8,129,440  

 

Identifiable long-lived tangible assets at September 30, 2019 and December 31, 2018   September 30,
2019
    December 31,
2018
 
United States   $ 7,885,775     $ 7,898,806  
China     514,798       230,634  
    $ 8,400,573     $ 8,129,440  

 

(a) The Company does not allocate any interest expense and general and administrative expense of its being a public company activities to its reportable segments as these activities are managed at a corporate level.